Literature DB >> 26610776

Intraoperative Parathyroid Hormone Monitoring: Optimal Utilization.

Kepal N Patel1, Raul Caso2.   

Abstract

Intraoperative parathyroid hormone (IOPTH) monitoring is a highly accurate surgical adjunct used to determine the extent of surgery in the setting of primary hyperparathyroidism. It is the successful interpretation of changes in PTH levels that is essential for using this technique in a way to optimize cure. Thus, it is imperative that the surgeon has an understanding of PTH dynamics and carefully chooses the appropriate IOPTH protocol and interpretation criteria that will best predict operative success, minimize unnecessary bilateral exploration, decrease the likelihood of resecting parathyroid glands that are not hypersecreting, and prevent recurrence.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Intraoperative PTH monitoring; Minimally invasive parathyroidectomy; PTH; Primary hyperparathyroidism

Mesh:

Substances:

Year:  2015        PMID: 26610776     DOI: 10.1016/j.soc.2015.08.005

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  10 in total

1.  Current practice in the surgical management of parathyroid disorders: a United Kingdom survey.

Authors:  K Varadharajan; N Choudhury
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-08-17       Impact factor: 2.503

Review 2.  Intraoperative assessment of parathyroid pathology in sporadic primary hyperparathyroidism: an institutional experience.

Authors:  Nicole A Cipriani; Krzysztof Glomski; Peter M Sadow
Journal:  Hum Pathol       Date:  2022-02-20       Impact factor: 3.526

3.  Minimally Invasive Parathyroidectomy: Can Intraoperative Parathyroid Hormone Monitoring be Omitted?

Authors:  Shalom Eligal; Michal Mekel; Ron Eliashar; Haggi Mazeh; Jeffrey M Weinberger; Mariya Neymark; Nir Hirshoren; Ido Mizrahi
Journal:  World J Surg       Date:  2022-04-11       Impact factor: 3.282

4.  Actual role of color-doppler high-resolution neck ultrasonography in primary hyperparathyroidism: a clinical review and an observational study with a comparison of 99mTc-sestamibi parathyroid scintigraphy.

Authors:  Giovanni Mariano Vitetta; Alberto Ravera; Giovanni Mensa; Luca Fuso; Pierluigi Neri; Alessandro Carriero; Stefano Cirillo
Journal:  J Ultrasound       Date:  2018-10-24

5.  The Effect of the Frequently Used Cinacalcet for pHPT during the COVID-19 Pandemic on Perioperative Decrease in Parathyroid Hormone.

Authors:  Olga Radulova-Mauersberger; Julia Keßler; Ulrich Keßler; Katrin Stange; Sandra Korn; Jürgen Weitz; Ulrich Bork
Journal:  J Clin Med       Date:  2022-04-04       Impact factor: 4.241

6.  Medicolegal implications of surgical errors and complications in neck surgery: A review based on the Italian current legislation.

Authors:  Andrea Polistena; Pierpaolo Di Lorenzo; Alessandro Sanguinetti; Claudio Buccelli; Giovanni Conzo; Adelaide Conti; Massimo Niola; Nicola Avenia
Journal:  Open Med (Wars)       Date:  2016-08-02

Review 7.  A Rare Case of Primary Hyperparathyroidism Caused by a Giant Solitary Parathyroid Adenoma.

Authors:  Ioannis Mantzoros; Despoina Kyriakidou; Konstantinos Galanos-Demiris; Christos Chatzakis; Styliani Parpoudi; Nikolaos Sapidis; Lydia Loutzidou; Orestis Ioannidis; Stamatis Angelopoulos; Konstantinos G Tsalis
Journal:  Am J Case Rep       Date:  2018-11-08

8.  Selective intra-operative parathyroid hormone in re-do neck exploration in parathyroidectomy: A case report.

Authors:  Henry To; Gregory Otto
Journal:  Int J Surg Case Rep       Date:  2019-02-28

9.  Contribution of intraoperative parathyroid hormone monitoring to the surgical success in minimal invasive parathyroidectomy.

Authors:  Ismail Ethem Akgün; Mehmet Taner Ünlü; Nurcihan Aygun; Mehmet Kostek; Mehmet Uludag
Journal:  Front Surg       Date:  2022-09-21

Review 10.  Advances in the diagnosis and the management of primary hyperparathyroidism.

Authors:  Ana Kashfia Islam
Journal:  Ther Adv Chronic Dis       Date:  2021-06-11       Impact factor: 5.091

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.